We are live on ! Find out more
TBIO

Translate Bio, Inc. Common Stock
TBIO

Delisted

TBIO was delisted on the 13th of September, 2021.

Back to rankings

150 hedge funds and large institutions have $1.18B invested in Translate Bio, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 51 increasing their positions, 44 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 21

27% more capital invested

Capital invested by funds: $936M → $1.18B (+$249M)

16% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 44

14% more funds holding

Funds holding: 132 → 150 (+18)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

80% less call options, than puts

Call options by funds: $2.1M | Put options by funds: $10.7M

Holders
150
Holders Change
+18
Holders Change %
+13.64%
% of All Funds
2.65%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
39
Increased
51
Reduced
44
Closed
21
Calls
$2.1M
Puts
$10.7M
Net Calls
-$8.55M
Net Calls Change
-$5.73M

Top Buyers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
+$34.5M
2
Macquarie Group
Macquarie Group
Australia
+$8.17M
3
BCPEMI
Bain Capital Public Equity Management II
Massachusetts
+$6.98M
4
Barclays
Barclays
United Kingdom
+$2.87M
5
BlackRock
BlackRock
New York
+$2.64M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$35.2M
2
AVA
Atlas Venture Advisors
Massachusetts
-$21.1M
3
Goldman Sachs
Goldman Sachs
New York
-$15M
4
RI
RTW Investments
New York
-$13.7M
5
GPP
Great Point Partners
Connecticut
-$12.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
151
Perceptive Advisors
New York
– -$4.29M -315,237 Closed
Alyeska Investment Group
152
Alyeska Investment Group
Illinois
– -$4.28M -314,450 Closed
PM
153
Prosight Management
Texas
– -$3.84M -282,100 Closed
LP
154
LMR Partners
United Kingdom
– -$2.55M -187,600 Closed
ECM
155
Endurant Capital Management
California
– -$2.4M -176,710 Closed
IAM
156
Ion Asset Management
Israel
– -$2.31M -170,000 Closed
Balyasny Asset Management
157
Balyasny Asset Management
Illinois
– -$1.05M -77,227 Closed
DI
158
DFPG Investments
Utah
– -$730K -50,000 Closed
OC
159
Oppenheimer & Co
New York
– -$299K -21,959 Closed
GCP
160
GSA Capital Partners
United Kingdom
– -$297K -21,857 Closed
DC
161
Davenport & Co
Virginia
– -$233K -17,100 Closed
KWMG
162
King Wealth Management Group
Florida
– -$231K -17,000 Closed
AA
163
AlphaCentric Advisors
Puerto Rico
– -$69K -5,100 Closed
CG
164
Cutler Group
California
– -$82.3K -4,596 Closed
MAM
165
Meeder Asset Management
Ohio
– -$43K -3,103 Closed
FHA
166
Flagship Harbor Advisors
Massachusetts
– -$28K -2,080 Closed
QT
167
Quantbot Technologies
New York
– -$8K -600 Closed
PCM
168
Prelude Capital Management
New York
– -$5K -400 Closed
PA
169
Parallel Advisors
California
– -$2K -137 Closed
GWMIA
170
Global Wealth Management Investment Advisory
Florida
– -$1K -90 Closed
EI
171
Ellevest Inc
New York
– +$322 +18 New
3 4 5 6
7

TBIO Hedge Fund Activity: Q4 2020 in Review

150 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Translate Bio, Inc. Common Stock (TBIO) for Q4 2020, worth a combined $1.18B — up 27% from $936M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new TBIO positions and 21 closed out — a net gain of 18 holders — while 51 added to existing stakes and 44 trimmed.

The largest buyer was Invesco, opening a new position worth an estimated $34.5M. The largest seller was State Street, cutting an estimated $35.2M.

  • 150 institutional investors held Translate Bio, Inc. Common Stock (TBIO) as of Q4 2020, up from 132 in Q3 2020.
  • Funds reported $1.18B of Translate Bio, Inc. Common Stock stock for Q4 2020, up 27% quarter-over-quarter.
  • 39 funds opened new Translate Bio, Inc. Common Stock positions in Q4 2020 and 21 closed out, a net change of +18 holders.
  • The largest Translate Bio, Inc. Common Stock buyer in Q4 2020 was Invesco, an estimated $34.5M added.
  • The largest Translate Bio, Inc. Common Stock seller in Q4 2020 was State Street, an estimated $35.2M sold.

Based on aggregated 13F filings for Q4 2020.